During the past decade, Nantong First People's Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nantong First People's Hospital" #1 sponsor was "Affiliated Hospital of Nantong University" with 2 trials, followed by "Ark Biosciences Inc." with 1 trials sponsored, "Beijing Tiantan Hospital" with 1 trials sponsored, "Nanjing First Hospital, Nanjing Medical University" with 1 trials sponsored and "PegBio Co., Ltd." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nantong First People's Hospital" #1 collaborator was "Affiliated Hospital of Nantong University" with 1 trials as a collaborator, "Beijing Hospital" with 1 trials as a collaborator, "Beijing Shijingshan Hospital" with 1 trials as a collaborator, "Central South University" with 1 trials as a collaborator and "Children's Hospital of Fudan University Qidong Branch" with 1 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Nantong First People's Hospital" are "Diabetic Kidney Disease" (1 trials), "Helicobacter Pylori Infection" (1 trials), "Insomnia Disorder" (1 trials), "Kawasaki Disease" (1 trials) and "Osteoporosis" (1 trials). Many other conditions were trialed in "Nantong First People's Hospital" in a lesser frequency.

Most popular intervention types in "Nantong First People's Hospital" are "Drug" (5 trials), "Diagnostic Test" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AK0529" (1 trials), "Clopidogrel and Aspirin" (1 trials), "Echocardiography, Genomics NGS sequencing" (1 trials) and "Femoston" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nantong First People's Hospital" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Nantong First People's Hospital". 1 are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Nantong First People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nantong First People's Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".